Today we're opening access to Omic's AI Scientist platform—making the same technology powering our internal drug discovery programs available to researchers worldwide.

From Internal to External

For the past three years, Omic's AI Scientist has been driving our internal pipeline programs:

  • 4 active programs across oncology, infectious disease, hematology, and cardiovascular
  • Dozens of validated targets discovered by AI
  • Hundreds of novel compounds designed by AI
  • Industry-leading accuracy on scientific reasoning benchmarks

Now, we're making this capability available to the broader research community.

Three Access Tiers

We're launching with three access levels:

AI Scientist ($39/month)

For individual researchers and academics:

  • PhD-level AI scientist for literature synthesis and analysis
  • Target discovery and mechanism exploration
  • Basic molecule design capabilities
  • Ideal for graduate students, postdocs, and independent researchers

AI Research Team ($399/month)

For research groups and small biotechs:

  • Multiple AI scientists working in parallel
  • 25x usage allocation
  • Digital Patient pipeline access
  • Advanced molecule design and optimization
  • Collaborative features for teams

Enterprise (Custom)

For pharmaceutical R&D organizations:

  • Unlimited AI scientist access
  • Full Digital Patient and virtual trial capabilities
  • Custom integrations with internal data systems
  • Dedicated support and training
  • On-premise deployment options

What You Can Do

The AI Scientist platform enables:

  • Literature synthesis: Instantly summarize and connect findings across millions of papers
  • Target discovery: Identify novel drug targets from multi-omics data
  • Mechanism exploration: Understand disease biology at the molecular level
  • Molecule design: Generate novel compounds with desired properties
  • Patient modeling: Build and interrogate Digital Patient models
  • Hypothesis testing: Computationally test ideas before wet lab work

Why Now?

We've spent seven years building and validating this technology. Our internal programs have demonstrated that AI can do real drug discovery. Now we want to amplify that impact by putting these tools in the hands of researchers everywhere.

The $39/month tier is particularly important to us. We believe every graduate student working on a disease should have access to PhD-level AI assistance. Cost shouldn't be a barrier to scientific progress.

Getting Started

Sign up at discover.omic.ai to get started. Enterprise customers can contact sales@omic.ai for a customized demo and deployment discussion.

The Mission Continues

This launch doesn't change our mission—we're still building biological superintelligence to end disease. But we've realized that the fastest path to that goal is putting our tools in the hands of the entire research community.

Every researcher who uses our AI Scientist helps advance the collective understanding of biology. And every insight they generate makes the AI smarter for everyone.

Let's end disease together.